The real reasons not to rely on severity scores

被引:7
作者
Cohen, Neal H. [1 ]
机构
[1] Univ Calif San Francisco, UCSF Sch Med, San Francisco, CA 94143 USA
关键词
severity scoring systems; APACHE II; critical illness; risk prediction; intensive care unit morbidity and mortality; clinical investigations; industry relationships; emerging technologies; SEVERE SEPSIS; ACUTE PHYSIOLOGY; APACHE-II; SYSTEM; SAFETY;
D O I
10.1097/CCM.0b013e3181b9d3e4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:334 / 335
页数:2
相关论文
共 14 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   Application of a population-based severity scoring system to individual patients results in frequent misclassification [J].
Booth, FV ;
Short, M ;
Shorr, AF ;
Arkins, N ;
Bates, B ;
Qualy, RL ;
Levy, H .
CRITICAL CARE, 2005, 9 (05) :R522-R529
[4]  
Chesbrough H., 2003, OPEN INNOVATION
[5]  
CIVETTA JM, 1990, CRIT CARE MED, V18, P1487
[6]   Integrating molecular medicine into the US health-care system: Opportunities, barriers, and policy challenges [J].
Deverka, P. A. ;
Doksum, T. ;
Carlson, R. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (04) :427-434
[7]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829
[8]   A NEW SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS-II) BASED ON A EUROPEAN NORTH-AMERICAN MULTICENTER STUDY [J].
LEGALL, JR ;
LEMESHOW, S ;
SAULNIER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2957-2963
[9]   Open innovation networks between academia and industry: an imperative for breakthrough therapies [J].
Melese, Teri ;
Lin, Salima M. ;
Chang, Julia L. ;
Cohen, Neal H. .
NATURE MEDICINE, 2009, 15 (05) :502-507
[10]   Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice [J].
Phillips, Kathryn A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2542-2544